RecruitingNCT03505216

Swiss Paediatric Airway Cohort

Sponsor

University of Bern

Enrollment

6,000 participants

Start Date

Jun 6, 2017

Study Type

OBSERVATIONAL

Conditions

Asthma Wheezing Cough Exercise Induced Bronchospasm Inspiratory Laryngeal Obstruction Dysfunctional Breathing

Summary

The Swiss Paediatric Airway Cohort (SPAC) is a national, prospective clinical cohort of children and adolescents who visit physicians in Switzerland for recurrent wheeze, cough, and exercise- or sleep-related respiratory problems. SPAC aims to answer important questions on clinical phenotypes, prognosis, diagnosis and treatment. SPAC is part of routine care, and only clinically indicated investigations are done. The comprehensive baseline assessment includes a detailed questionnaire to families, plus test results, diagnoses and treatments from hospital records. Follow-up is via monthly questionnaires the first 12 months and thereafter annual questionnaires to families, and data from follow-up visits. Currently, 4344 patients from 10 clinics and hospitals in Switzerland (Aarau, Basel, Bern, Chur, Horgen, Lausanne, Luzern, St. Gallen, Worb, Zurich) have been enrolled. SPAC provides real-life data on children visiting the Swiss health care system for common respiratory problems. It will provide a research platform for health services research, and for nested clinical and transitional studies. Publications and plain language summaries are listed on the study website: https://www.spac-study.ch/publikationen/

Eligibility

Min Age: 0 YearsMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This trial is building a national registry of children and teenagers in Switzerland who have breathing or lung problems, to better understand how these conditions develop over time and what factors influence them. **You may be eligible if...** - Your child is between 0 and 16 years old - Your child lives in Switzerland - Your child is being seen at a children's lung specialist clinic for breathing or respiratory problems - Parents and children aged 14 and over must be able to sign a consent form **You may NOT be eligible if...** - Your child has already been diagnosed with cystic fibrosis, primary ciliary dyskinesia (a rare condition affecting tiny hairs in the airways), severe heart disease, a cancer diagnosis, a neuromuscular disease, or a severe disability Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(12)

Vienna Open Medical Institute

Vienna, Austria

Children's hospital Aarau

Aarau, Switzerland

University Children's hospital Basel, UKBB

Basel, Switzerland

Institute of Social and Preventive Medicine

Bern, Switzerland

University Children's Hospital Bern, Inselspital

Bern, Switzerland

Children's Hospital Chur

Chur, Switzerland

Pulmonology clinic, Horgen

Horgen, Switzerland

University Children's hospital Lausane, CHUV

Lausanne, Switzerland

Children's hospital Lucerne

Lucerne, Switzerland

Children's hospital St. Gallen

Sankt Gallen, Switzerland

Pulmonology clinic, Worb

Worb, Switzerland

University Children's Hospital Zurich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03505216

Related Trials

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

NCT06307665135 locations

Personalized Environment and Genes Study

NCT003412371 location

ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia

NCT073996659 locations

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

NCT06023589143 locations

PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults

NCT069811693 locations